RAPT Therapeutics, Inc. Deferred Revenue
RAPT Therapeutics, Inc. had Deferred Revenue of $645.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueCurrent · last filed 2023-03-14
- 2022-03-31: Deferred Revenue, Current $645.00K.
- 2021-12-31: Deferred Revenue, Current $1.02M.
- 2021-09-30: Deferred Revenue, Current $1.54M.
- 2021-06-30: Deferred Revenue, Current $2.28M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2022-03-31 | $645.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.02M 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.54M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.28M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.13M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $4.10M 10-K · filed 2022-03-10 |
| 2020-09-30 | $5.13M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $6.01M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $5.76M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.00M 10-K · filed 2021-03-11 |